
Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
2 April 2025
MDPI INSIGHTS: The CEO's Letter #21 - Annual Report, Swiss Consortium, IWD, ICARS, Serbia

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Releases 2024 Annual Achievements Report
I’m pleased to share the release of MDPI’s 2024 Annual Achievements Report, which reflects our commitment to efficiency, transparency, and excellence in scholarly communication. The report showcases key themes related to our growth (highlighting our workforce expansion, new offices, journal milestones), excellence (editorial and publishing advancements), people (talent development and training), and community (partnerships, conferences, and outreach).
MDPI continues to build connections and drive scientific progress
Our mission remains clear: to support researchers worldwide by delivering an efficient, high-quality publishing experience while strengthening the global Open Access (OA) movement.
Advancing Open Access: A Global Knowledge Hub
In 2024, we published 238,000 peer-reviewed OA articles, reaching over 25 million downloads. This reinforces MDPI’s role as a global knowledge hub, breaking down barriers to access and ensuring that high-quality research is freely available to everyone. As part of the OA movement, we are actively democratizing knowledge, making scientific advancements accessible to researchers, policymakers, educators, and the public, without the restrictions of traditional paywalls.
Expanding our Workforce and Strengthening Research Integrity
Our global presence grew in 2024 with the opening of a new Seoul office, and our workforce expanded to 6,650 staff across 21 offices. This reflects our continued growth mindset and investment in global accessibility. We also continued to take a proactive stance on our commitment to research integrity, tripling our team in this area and joining STM’s Integrity Hub and United2Act. This means more rigorous quality control, stronger safeguards, and collaboration with global initiatives to detect and combat unethical publishing practices at an industry level. Our growth is about reinforcing our role as a trusted, ethical, and accessible publishing platform for researchers worldwide.
Growing Partnerships and Impact in Scholarly Communication
MDPI’s partnerships continue to thrive, with over 900 institutional collaborations, including a landmark agreement with ZB MED in Germany, covering more than 100 universities. Additionally, more than 90% of evaluated MDPI journals have been accepted into Web of Science, including 60 new acceptances in 2024, with nearly 300 journals expected to receive a Journal Impact Factor in 2025. In the same period, 37 MDPI journals were accepted into Scopus, bringing our total indexed titles to 306. Most importantly, 95% of authors rate their experience with MDPI as excellent or good – an achievement that underscores our dedication to serving the research community.
I encourage you to read through our Annual Report, which highlights these milestones and our vision for the future. Thank you for being part of MDPI’s journey in advancing open science.
Impactful Research
MDPI Renews Partnership with CSAL to Support Swiss Universities
I am pleased to announce the renewal of our partnership with the Consortium of Swiss Academic Libraries (CSAL) for 2025. This extension reinforces MDPI's dedication to advancing open science through transparency, efficiency, and collaboration.
Our renewed agreement with CSAL strengthens support for Swiss universities, ensuring that gold open access publishing remains both accessible and affordable for researchers across Switzerland. Among the institutions participating in this agreement are ETH Zurich and EPFL Lausanne, along with 20 other leading institutions, further expanding the reach and impact of our collaborative efforts.
To date, over 3.9 million researchers have published their findings in MDPI journals, a testament to our role in enhancing Switzerland's position as a hub for university education and research.
Inside MDPI
Celebrating International Women's Day: Accelerating Action
In honour of International Women's Day, MDPI embraced the theme “Accelerate Action,” a global call to advance women's progress by implementing effective strategies and resources. As part of our commitment, we highlighted how open access publishing empowers female voices in research and academia.
Throughout March, we featured original blogs authored by MDPI’s female contributors, showcasing the successes of our journals and employees, and addressing pressing topics such as women's health.
“Open Access supports women in education”
Women Accelerating Action Outside of MDPI
MDPI employee Ana Zdravkovic is accelerating action outside of her MDPI role as a Production Assistant. Working with like-minded women at the award-winning Belgrade-based organization UZOR OsnaŽene (meaning ‘empowered women’), they identify serious flaws in cybersecurity, and help protect women and children against online predators by providing evidence to improve legislation and laws around cyber-attacks.
In this article, we interview Ana, celebrating the important and inspiring work that she and the organisation do.
How Open Access Supports Women in Education
Every day, women and girls face barriers in education or career progression. This is caused by a range of factors, including social expectations, poverty, and poor infrastructure.
Quality opportunities and participation in the education system by women is essential to achieving equality and fulfilling their human rights.
Here, we examine how Open Access supports women in education by removing barriers and ensuring that vital research is accessible.
Recent Advancements in Research on Endometriosis
March is Endometriosis Action Month. Endometriosis is a medical condition affecting women and young girls of reproductive age, often causing symptoms such as severe pelvic pain, irregular periods, and infertility.
More research on endometriosis is still urgently needed.
This research will help develop efficient diagnoses and better treatment for those struggling with the condition.
In this article, we explore what endometriosis is and discuss the latest research advancements on the disease.
We also curated a selection of MDPI journals, articles, and Special Issues focusing on gender equity, women in the workplace, and women’s health. Find out more about these by visiting our IWD – Accelerate Action landing page.
As I reflect on the month of March and International Women’s Day, I would like to take a moment to recognize and thank all of the incredible women at MDPI for your dedication to democratizing knowledge and shaping open access. Your contributions are invaluable, and they continue to shape the future of MDPI.
Coming Together for Science
The International Conference on Advanced Remote Sensing (ICARS 2025)
The International Conference on Advanced Remote Sensing (ICARS 2025) took place from 26–28 March 2025, in Barcelona, Spain. It was chaired by Prof. Dr. Fabio Tosti from the Faringdon Research Centre for Non-Destructive Testing and Remote Sensing (UK), Prof. Dr. Andrea Benedetto from University Roma Tre (Italy), and Prof. Dr. Luis Ángel Ruiz from Universitat Politècnica de València (UPV, Spain).
Over three days, the conference explored innovations in Earth and environmental sciences, engineering advancements, and practical applications in biological and agricultural fields.
I am pleased to share that the 1st edition of ICARS 2025 was a great success, with 133 attendees out of 146 registrations. The event featured 43 short talks, 64 posters, and 103 accepted abstracts, along with nine keynote speakers and a major panel with five expert panellists.
Over 60 attendees joined the conference dinner, and the event received outstanding feedback.
The main goal of ICARS2025 was to cover how advanced remote sensing technologies are transforming our approach to global challenges.
Awards
Four awards were presented at the conclusion of the conference, sponsored by the journal Remote Sensing: Best Poster Award (€400), Best Oral Presentation Award (€400), and two Early Career Researcher Awards (1st prize: €600 and 2nd prize: €200).
Thank you to our Partnering Societies
We are grateful for the support of our four partnering societies and nine media partners, who played an important role in promoting the conference. Special thanks to our partnering societies: the European Federation of Geologists (EFG), Geoscience Energy Society of Great Britain (GESGB), Asociación Española de Teledetección (AET) – the Spanish Association of Remote Sensing, and the International Society for Digital Earth (ISDE).
Upcoming In-Person Event
31 March–2 April 2025
Plants 2025: From Seeds to Food Security
Location: Barcelona, Spain
This event will gather plant scientists to discuss the latest research on how to feed a growing population while maintaining a sustainable agro-ecosystem.
Find more upcoming MDPI events here.
Closing Thoughts
MDPI Serbia Salon 2025: A Gathering of Academic Excellence
On Tuesday, 18 March, we successfully concluded our first MDPI Serbia Salon in Belgrade. This event provided a great opportunity to showcase MDPI’s achievements, strengthen connections with the Serbian academic community, and highlight our role as the largest publisher in Serbia. We were honoured to welcome Prof. Dr. Sergej M. Ostojić, Editor-in-Chief of MDPI journal Clinical Bioenergetics, as a guest speaker.
Over the past five years, MDPI has experienced continuous growth in Serbia, with an increasing number of publications, an expansion of Editorial Board memberships, and a greater number of active peer reviewers. The Salon allowed us to express our thanks to the Serbian research community while gathering feedback from attendees representing several major universities.
Discussion topics
As part of the event, I delivered an opening speech highlighting MDPI’s achievements and direction.
The event featured presentations from MDPI colleagues, including discussions on open science, publishing ethics, and our achievements in Serbia.
A special thank-you to all our MDPI presenters, panellists, and organizers who made his event a success. I hope the MDPI Serbia Salon becomes a tradition for years to come, creating connections within the Serbian research community.
Visit to the Science Fund of Serbia and The Ministry of Science
During my visit to Belgrade, I had the opportunity to join my colleagues Emir Ramadani (Operations Manager) and Nevena Blagojev (Journal Relations Manager) in meetings with the Science Fund of Serbia and the Ministry of Science, where we received strong support for our work in Serbia.
Both organizations highly value our presence in and commitment to Serbia, where we employ over 640 staff across our two offices in Belgrade and Novi Sad. We take great pride in creating job opportunities and supporting the community in Serbia.
“There’s a lot of exciting activity happening in MDPI Serbia”
Speaking with our Serbian Colleagues
Finally, I had the opportunity to speak with our Serbian colleagues about our initiatives to expand and to improve our marketing & communication and public relations activities.
It was great to have an open discussion with colleagues – both in person and with the hundreds who joined online.
This visit to Belgrade had been a long time coming for me. Serbia is our largest operation in Europe and there’s a lot of exciting activity happening in MDPI Serbia, including the launch of a new office floor in Novi Sad and the growth and expansion of our teams.
I look forward to returning soon and continuing to support our colleagues across our Serbian offices.
Chief Executive Officer
MDPI AG
28 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Pediatric Oncology” Section

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Pediatric Oncology” Section, which are listed below:
1. “Rhabdomyosarcoma of the Biliary Tract in Children: Analysis of Single Center Experience”
by Ewa Święszkowska, Dorota Broniszczak, Piotr Kaliciński, Marek Szymczak, Marek Stefanowicz, Wiesława Grajkowska and Bożenna Dembowska-Bagińska
Cancers 2024, 16(17), 3110; https://doi.org/10.3390/cancers16173110
Available online: https://www.mdpi.com/2072-6694/16/17/3110
2. “Progress Toward Epigenetic Targeted Therapies for Childhood Cancer”
by Athanasia Liapodimitri, Ashley R. Tetens, Jordyn Craig-Schwartz, Kayleigh Lunsford, Kegan O. Skalitzky and Michael A. Koldobskiy
Cancers 2024, 16(24), 4149; https://doi.org/10.3390/cancers16244149
Available online: https://www.mdpi.com/2072-6694/16/24/4149
3. “Long-Term Outcomes of Childhood Acute Lymphocytic Leukemia Treated with Adapted Berlin–Frankfurt–Münster (BFM) Protocols: A Multicentric Analysis from a Developing Country”
by Patricia Regina Cavalcanti Barbosa Horn, Marilza de Moura Ribeiro-Carvalho, Alice Maria Boulhosa de Azevedo, Adriana Martins de Sousa, Simone Faria, Cristina Wiggers, Soraia Rouxinol, Marcia Trindade Schramm, Bárbara Sarni Sanches, Nathalia Lopez Duarte et al.
Cancers 2024, 16(16), 2898; https://doi.org/10.3390/cancers16162898
Available online: https://www.mdpi.com/2072-6694/16/16/2898
4. “Acute Pancreatitis in Pediatric Acute Lymphoblastic Leukemia (AcuPA Study): A Nationwide Survey in Poland”
by Anna Morawiak, Małgorzata Salamonowicz-Bodzioch, Aleksandra Królak, Krzysztof Kałwak, Joanna Owoc-Lempach, Jerzy Kowalczyk, Joanna Zawitkowska, Tomasz Szczepański, Ninela Irga-Jaworska, Elżbieta Adamkiewicz-Drożyńska et al.
Cancers 2024, 16(15), 2640; https://doi.org/10.3390/cancers16152640
Available online: https://www.mdpi.com/2072-6694/16/15/2640
5. “Efficacy and Safety of Acupuncture and Related Techniques in the Management of Oncological Children and Adolescent Patients: A Systematic Review”
by Esther Martínez García, M. Betina Nishishinya Aquino, Ofelia Cruz Martínez, Yiming Ren, Ruyu Xia, Yutong Fei and Carles Fernández-Jané
Cancers 2024, 16(18), 3197; https://doi.org/10.3390/cancers16183197
Available online: https://www.mdpi.com/2072-6694/16/18/3197
6. “Panobinostat Synergizes with Chemotherapeutic Agents and Improves Efficacy of Standard-of-Care Chemotherapy Combinations in Ewing Sarcoma Cells”
by Kaitlyn H. Smith, Erin M. Trovillion, Chloe Sholler, Divya Gandra, Kimberly Q. McKinney, David Mulama, Karl J. Dykema, Abhinav B. Nagulapally, Javier Oesterheld and Giselle L. Saulnier Sholler
Cancers 2024, 16(21), 3565; https://doi.org/10.3390/cancers16213565
Available online: https://www.mdpi.com/2072-6694/16/21/3565
7. “Characterization of Patient Activation among Childhood Cancer Survivors in the St. Jude Lifetime Cohort Study (SJLIFE)”
by Megan E. Ware, Angelica De La Cruz, Qian Dong, Kyla Shelton, Tara M. Brinkman, I-Chan Huang, Rachel Webster, Brian Potter, Kevin Krull, Sedigheh Mirzaei et al.
Cancers 2024, 16(18), 3220; https://doi.org/10.3390/cancers16183220
Available online: https://www.mdpi.com/2072-6694/16/18/3220
8. “VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma”
by Natalia Muñoz Perez, Juliana M. Pensabene, Phillip M. Galbo, Jr., Negar Sadeghipour, Joanne Xiu, Kirsten Moziak, Rita M. Yazejian, Rachel L. Welch, W. Robert Bell, Soma Sengupta et al.
Cancers 2024, 16(15), 2629; https://doi.org/10.3390/cancers16152629
Available online: https://www.mdpi.com/2072-6694/16/15/2629
9. “Characteristics and Management of Children with Appendiceal Neuroendocrine Neoplasms: A Single-Center Study”
by Stefano Mastrangelo, Giorgio Attinà, Guido Rindi, Alberto Romano, Palma Maurizi and Antonio Ruggiero
Cancers 2024, 16(20), 3440; https://doi.org/10.3390/cancers16203440
Available online: https://www.mdpi.com/2072-6694/16/20/3440
10. “Impaired DNA Double-Strand Break Repair in Irradiated Sheep Lung Fibroblasts: Late Effects of Previous Irradiation of the Spinal Thecal Sac”
by Bassem Youssef, Charbel Feghaly, Joelle Al Choboq, Jolie Bou-Gharios, Rafka Challita, Joyce Azzi, Hanine Bou Hadir, Fabienne Abi Antoun, Tarek Araji, Phillip J. Taddei et al.
Cancers 2024, 16(17), 2968; https://doi.org/10.3390/cancers16172968
Available online: https://www.mdpi.com/2072-6694/16/17/2968
11. “Integrated Psychological Services in Pediatric Oncology: Caregiver Perspectives at Diagnosis”
by Emily Bernstein, Anna M. Jones, Niki Jurbergs, Jennifer L. Harman, Sean Phipps and R. Elyse Heidelberg
Cancers 2024, 16(18), 3137; https://doi.org/10.3390/cancers16183137
Available online: https://www.mdpi.com/2072-6694/16/18/3137
12. “Non-Syndromic and Syndromic Defects in Children with Extracranial Germ Cell Tumors: Data of 2610 Children Registered with the German MAKEI 96/MAHO 98 Registry Compared to the General Population”
by Judit H. Schultewolter, Anke Rissmann, Dietrich von Schweinitz, Michael Frühwald, Claudia Blattmann, Lars Fischer, Björn Sönke Lange, Rüdiger Wessalowski, Birgit Fröhlich, Wolfgang Behnisch et al.
Cancers 2024, 16(11), 2157; https://doi.org/10.3390/cancers16112157
Available online: https://www.mdpi.com/2072-6694/16/11/2157
13. “Telomere Length in Adolescent and Young Adult Survivors of Childhood Cancer”
by Meerim Park, Dong-Eun Lee, Yuna Hong, Jin Kyung Suh, Jun Ah Lee, Myungshin Kim and Hyeon Jin Park
Cancers 2024, 16(13), 2344; https://doi.org/10.3390/cancers16132344
Available online: https://www.mdpi.com/2072-6694/16/13/2344
14. “Rare Oncogenic Fusions in Pediatric Central Nervous System Tumors: A Case Series and Literature Review”
by Melek Ahmed, Anne Sieben, Toon Van Genechten, Sasha Libbrecht, Nathalie Gilis, Mania De Praeter, Christophe Fricx, Pierluigi Calò, Claude Van Campenhout, Nicky D’Haene et al.
Cancers 2024, 16(19), 3344; https://doi.org/10.3390/cancers16193344
Available online: https://www.mdpi.com/2072-6694/16/19/3344
15. “Therapeutic Parent–Child Communication and Health Outcomes in the Childhood Cancer Context: A Scoping Review”
by Heeyeon Son and Nani Kim
Cancers 2024, 16(11), 2152; https://doi.org/10.3390/cancers16112152
Available online: https://www.mdpi.com/2072-6694/16/11/2152
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
25 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the Section “Cancer Drug Development”

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the Section “Cancer Drug Development”, which are listed below.
1. “Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer”
by Maria George Elias, Shadma Fatima, Timothy J. Mann, Shawan Karan, Meena Mikhael, Paul de Souza, Christopher P. Gordon, Kieran F. Scott and Janice R. Aldrich-Wright
Cancers 2024, 16(14), 2544; https://doi.org/10.3390/cancers16142544
Available online: https://www.mdpi.com/2072-6694/16/14/2544
2. “A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers”
by Lorenzo Magrassi, Giulia Pinton, Sabino Luzzi, Sergio Comincini, Andrea Scravaglieri, Valentina Gigliotti, Bianca Laura Bernardoni, Ilaria D’Agostino, Francesca Juretich, Concettina La Motta et al.
Cancers 2024, 16(13), 2397; https://doi.org/10.3390/cancers16132397
Available online: https://www.mdpi.com/2072-6694/16/13/2397
3. “Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer”
by Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa et al.
Cancers 2024, 16(14), 2545; https://doi.org/10.3390/cancers16142545
Available online: https://www.mdpi.com/2072-6694/16/14/2545
4. “Dose Optimization of Targeted Therapies for Oncologic Indications”
by Marjorie E. Zettler
Cancers 2024, 16(12), 2180; https://doi.org/10.3390/cancers16122180
Available online: https://www.mdpi.com/2072-6694/16/12/2180
5. “The Anticancer Application of Delivery Systems for Honokiol and Magnolol”
by Katarzyna Dominiak, Aleksandra Gostyńska, Michał Szulc and Maciej Stawny
Cancers 2024, 16(12), 2257; https://doi.org/10.3390/cancers16122257
Available online: https://www.mdpi.com/2072-6694/16/12/2257
6. “Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment”
by Taufeeque Ali, Daniel Li, Thilini Nimasha Fernando Ponnamperumage, Alexis Kimberly Peterson, Jatin Pandey, Kulsum Fatima, John Brzezinski, Julia Anna Rose Jakusz, Hanlun Gao, Gilbert Edward Koelsch et al.
Cancers 2024, 16(12), 2171; https://doi.org/10.3390/cancers16122171
Available online: https://www.mdpi.com/2072-6694/16/12/2171
7. “Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives”
by Francesca Carosi, Elisabetta Broseghini, Laura Fabbri, Giacomo Corradi, Riccardo Gili, Valentina Forte, Roberta Roncarati, Daria Maria Filippini and Manuela Ferracin
Cancers 2024, 16(15), 2752; https://doi.org/10.3390/cancers16152752
Available online: https://www.mdpi.com/2072-6694/16/15/2752
8. “Antibody-Drug Conjugates in Urothelial Cancer: From Scientific Rationale to Clinical Development”
by Whi-An Kwon, Seo-Yeon Lee, Tae Yoong Jeong, Hyeon Hoe Kim and Min-Kyung Lee
Cancers 2024, 16(13), 2420; https://doi.org/10.3390/cancers16132420
Available online: https://www.mdpi.com/2072-6694/16/13/2420
9. “Mechanisms of the Antineoplastic Effects of New Fluoroquinolones in 2D and 3D Human Breast and Bladder Cancer Cell Lines”
by Nicole Ferrario, Emanuela Marras, Veronica Vivona, Federica Randisi, Antonino Nicolò Fallica, Agostino Marrazzo, Gianpaolo Perletti and Marzia Bruna Gariboldi
Cancers 2024, 16(12), 2227; https://doi.org/10.3390/cancers16122227
Available online: https://www.mdpi.com/2072-6694/16/12/2227
10. “Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review”
by Lucillia Bezu, Dilara Akçal Öksüz, Max Bell, Donal Buggy, Oscar Diaz-Cambronero, Mats Enlund, Patrice Forget, Anil Gupta, Markus W. Hollmann, Daniela Ionescu et al.
Cancers 2024, 16(13), 2304; https://doi.org/10.3390/cancers16132304
Available online: https://www.mdpi.com/2072-6694/16/13/2304
11. “Target-Driven Tissue-Agnostic Drug Approvals—A New Path of Drug Development”
by Kyaw Z. Thein, Yin M. Myat, Byung S. Park, Kalpana Panigrahi and Shivaani Kummar
Cancers 2024, 16(14), 2529; https://doi.org/10.3390/cancers16142529
Available online: https://www.mdpi.com/2072-6694/16/14/2529
12. “Overcoming Chemoresistance in Cancer: The Promise of Crizotinib”
by Sanaa Musa, Noor Amara, Adan Selawi, Junbiao Wang, Cristina Marchini, Abed Agbarya and Jamal Mahajna
Cancers 2024, 16(13), 2479; https://doi.org/10.3390/cancers16132479
Available online: https://www.mdpi.com/2072-6694/16/13/2479
13. “Molecular Interactions of the Plant Steroid Hormone Epibrassinolide on Human Drug-Sensitive and Drug-Resistant Small-Cell Lung Carcinoma Cells”
by David Sadava and Shiuan Chen
Cancers 2024, 16(22), 3812; https://doi.org/10.3390/cancers16223812
Available online: https://www.mdpi.com/2072-6694/16/22/3812
14. “Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies”
by Christiana Mo, Michelle Sterpi, Hyein Jeon and Fernand Bteich
Cancers 2024, 16(16), 2854; https://doi.org/10.3390/cancers16162854
Available online: https://www.mdpi.com/2072-6694/16/16/2854
15. “Genotoxic and Anti-Migratory Effects of Camptothecin Combined with Celastrol or Resveratrol in Metastatic and Stem-like Cells of Colon Cancer”
by Helena Moreira, Anna Szyjka, Dorota Bęben, Oliwia Siwiela, Anna Radajewska, Nadia Stankiewicz, Małgorzata Grzesiak, Benita Wiatrak, Fathi Emhemmed, Christian D. Muller et al.
Cancers 2024, 16(19), 3279; https://doi.org/10.3390/cancers16193279
Available online: https://www.mdpi.com/2072-6694/16/19/3279
You are invited to view and submit relevant papers to the journal Cancers.
Cancers Editorial Office
25 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Tumor Microenvironment” Section

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Tumor Microenvironment” Section, which are listed below:
1. “TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications”
by Chuqi Wang, Jordan Yong Ming Tan, Nishtha Chitkara and Shruti Bhatt
Cancers 2024, 16(17), 3069; https://doi.org/10.3390/cancers16173069
Available online: https://www.mdpi.com/2072-6694/16/17/3069
2. “The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of View”
by Federico Mosna
Cancers 2024, 16(13), 2359; https://doi.org/10.3390/cancers16132359
Available online: https://www.mdpi.com/2072-6694/16/13/2359
3. “Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions”
by Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, Giulia de Martino and Vanessa Desantis
Cancers 2024, 16(13), 2438; https://doi.org/10.3390/cancers16132438
Available online: https://www.mdpi.com/2072-6694/16/13/2438
4. “Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems”
by Dragana Nikitovic, Ekaterina Kukovyakina, Aikaterini Berdiaki, Alexandros Tzanakakis, Anna Luss, Elizaveta Vlaskina, Anne Yagolovich, Aristides Tsatsakis and Andrey Kuskov
Cancers 2024, 16(22), 3768; https://doi.org/10.3390/cancers16223768
Available online: https://www.mdpi.com/2072-6694/16/22/3768
5. “Antibody-Based Therapies for Peripheral T-Cell Lymphoma”
by Nazila Shafagati, Suman Paul, Sima Rozati and Cole H. Sterling
Cancers 2024, 16(20), 3489; https://doi.org/10.3390/cancers16203489
Available online: https://www.mdpi.com/2072-6694/16/20/3489
6. “Importance of Michaelis Constants for Cancer Cell Redox Balance and Lactate Secretion—Revisiting the Warburg Effect”
by Michael Niepmann
Cancers 2024, 16(13), 2290; https://doi.org/10.3390/cancers16132290
Available online: https://www.mdpi.com/2072-6694/16/13/2290
7. “Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance”
by Abdulaziz M. Eshaq, Thomas W. Flanagan, Sofie-Yasmin Hassan, Sara A. Al Asheikh, Waleed A. Al-Amoudi, Simeon Santourlidis, Sarah-Lilly Hassan, Maryam O. Alamodi, Marcelo L. Bendhack, Mohammed O. Alamodi et al.
Cancers 2024, 16(15), 2754; https://doi.org/10.3390/cancers16152754
Available online: https://www.mdpi.com/2072-6694/16/15/2754
8. “Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma”
by Masaki Uchihara, Akiyo Tanabe, Yuki Kojima, Tatsunori Shimoi, Akiko Miyagi Maeshima, Kotaro Umamoto, Akihiko Shimomura, Chikako Shimizu, Yuto Yamazaki, Eijiro Nakamura et al.
Cancers 2024, 16(12), 2191; https://doi.org/10.3390/cancers16122191
Available online: https://www.mdpi.com/2072-6694/16/12/2191
9. “Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies”
by Patrizia Limonta, Raffaella Chiaramonte and Lavinia Casati
Cancers 2024, 16(16), 2861; https://doi.org/10.3390/cancers16162861
Available online: https://www.mdpi.com/2072-6694/16/16/2861
10. “Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component”
by Hubert Pakula, Filippo Pederzoli, Giuseppe Nicolò Fanelli, Pier Vitale Nuzzo, Silvia Rodrigues and Massimo Loda
Cancers 2024, 16(21), 3685; https://doi.org/10.3390/cancers16213685
Available online: https://www.mdpi.com/2072-6694/16/21/3685
11. “A Molecular Hypothesis on Malignant Transformation of Oral Lichen Planus: A Systematic Review and Meta-Analysis of Cancer Hallmarks Expression in This Oral Potentially Malignant Disorder”
by Carmen Keim-del Pino, Pablo Ramos-García and Miguel Ángel González-Moles
Cancers 2024, 16(15), 2614; https://doi.org/10.3390/cancers16152614
Available online: https://www.mdpi.com/2072-6694/16/15/2614
12. “Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour”
by Valéria Tavares, Joana Savva-Bordalo, Mariana Rei, Joana Liz-Pimenta, Joana Assis, Deolinda Pereira and Rui Medeiros
Cancers 2024, 16(13), 2356; https://doi.org/10.3390/cancers16132356
Available online: https://www.mdpi.com/2072-6694/16/13/2356
13. “Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment”
by Anghesom Ghebremedhin, Dipti Athavale, Yanting Zhang, Xiaodan Yao, Curt Balch and Shumei Song
Cancers 2024, 16(19), 3410; https://doi.org/10.3390/cancers16193410
Available online: https://www.mdpi.com/2072-6694/16/19/3410
14 “Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance”
by Shauna McClelland, Pamela J. Maxwell, Cristina Branco, Simon T. Barry, Cath Eberlein and Melissa J. LaBonte
Cancers 2024, 16(16), 2797; https://doi.org/10.3390/cancers16162797
Available online: https://www.mdpi.com/2072-6694/16/16/2797
15. “Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917”
by Georgette A. Radford, Laura Vrbanac, Rebekah T. de Nys, Daniel L. Worthley, Josephine A. Wright, Jeff Hasty and Susan L. Woods
Cancers 2024, 16(17), 2971; https://doi.org/10.3390/cancers16172971
Available online: https://www.mdpi.com/2072-6694/16/17/2971
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
25 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Infectious Agents and Cancer” Section

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Infectious Agents and Cancer” Section, which are listed below:
1. “Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection”
by Pompilia Radu, Chiara Becchetti, Jonas Schropp, Patrick Schmid, Patrizia Künzler-Heule, Joachim Mertens, Darius Moradpour, Beat Müllaupt, David Semela, Francesco Negro et al.
Cancers 2024, 16(14), 2573; https://doi.org/10.3390/cancers16142573
Available online: https://www.mdpi.com/2072-6694/16/14/2573
2. “Dihydrotestosterone Enhances MICA-Mediated Immune Responses to Epstein–Barr Virus-Associated Gastric Carcinoma”
by Donghyun Seo, Hyeji Byun, Miyeon Cho, Sun Hee Lee, Sohyun Youn, Junho Lee, Inuk Jung, Hyosun Cho and Hyojeung Kang
Cancers 2024, 16(18), 3219; https://doi.org/10.3390/cancers16183219
Available online: https://www.mdpi.com/2072-6694/16/18/3219
3. “Vaginal Intraepithelial Neoplasia (VaIN) after Hysterectomy Is Strongly Associated with Persistent HR-HPV Infection”
by Maria Teresa Bruno, Marco Marzio Panella, Gaetano Valenti, Salvatore Di Grazia, Francesco Sgalambro, Jessica Farina, Miriam Previti and Liliana Mereu
Cancers 2024, 16(14), 2524; https://doi.org/10.3390/cancers16142524
Available online: https://www.mdpi.com/2072-6694/16/14/2524
4. “Potential Therapeutic Targets for the Treatment of HPV-Associated Malignancies”
by Ziyao Lu, Shahab Haghollahi and Muhammad Afzal
Cancers 2024, 16(20), 3474; https://doi.org/10.3390/cancers16203474
Available online: https://www.mdpi.com/2072-6694/16/20/3474
5. “A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer”
by Xu Xu, Shih-Long Yan, Yi-Te Yo, Peiyu Chiang, Chan-Yen Tsai, Lih-Ling Lin and Albert Qin
Cancers 2024, 16(17), 3052; https://doi.org/10.3390/cancers16173052
Available online: https://www.mdpi.com/2072-6694/16/17/3052
6. “HPV and Lung Cancer: A Systematic Review”
by Telma Sequeira, Rui Pinto, Carlos Cardoso, Catarina Almeida, Rita Aragão, Teresa Almodovar, Manuel Bicho, Maria Clara Bicho and Cristina Bárbara
Cancers 2024, 16(19), 3325; https://doi.org/10.3390/cancers16193325
Available online: https://www.mdpi.com/2072-6694/16/19/3325
7. “De-Escalation Strategies in HPV-Associated Oropharynx Cancer: A Historical Perspective with Future Direction”
by Clinton Wu, Paulina Kuzmin and Ricklie Julian
Cancers 2024, 16(15), 2733; https://doi.org/10.3390/cancers16152733
Available online: https://www.mdpi.com/2072-6694/16/15/2733
8. “The Intersection of the Oral Microbiome and Salivary Metabolites in Head and Neck Cancer: From Diagnosis to Treatment”
by Maria Gonzalez Agurto, Nicolas Olivares, Gisela Canedo-Marroquin, Daniela Espinoza and Sofia C. Tortora
Cancers 2024, 16(20), 3545; https://doi.org/10.3390/cancers16203545
Available online: https://www.mdpi.com/2072-6694/16/20/3545
9. “The Impact of Urine-Sample HPV Testing on the Effectiveness of Screening for Cervical Cancer: An Umbrella Review”
by Wojciech Miazga, Tomasz Tatara, Katarzyna Wnuk, Mariusz Gujski, Jarosław Pinkas and Urszula Religioni
Cancers 2024, 16(12), 2244; https://doi.org/10.3390/cancers16122244
Available online: https://www.mdpi.com/2072-6694/16/12/2244
10. “Functional Targets for Epstein-Barr Virus BART MicroRNAs in B Cell Lymphomas”
by Devin N. Fachko, Bonnie Goff, Yan Chen and Rebecca L. Skalsky
Cancers 2024, 16(20), 3537; https://doi.org/10.3390/cancers16203537
Available online: https://www.mdpi.com/2072-6694/16/20/3537
11. “Tumor-Associated Edema in Children with Kaposi Sarcoma: 14 Years’ Experience at Kamuzu Central Hospital, Lilongwe, Malawi”
by Fatsani Rose Manase, Allison Silverstein, William Kamiyango, Jimmy Villiera, Clement Dziwe, Claudia Wallrauch, Tom Heller, Mark Zobeck, Tamiwe Tomoka, Michael E. Scheurer et al.
Cancers 2024, 16(22), 3769; https://doi.org/10.3390/cancers16223769
Available online: https://www.mdpi.com/2072-6694/16/22/3769
12. “Role of Artificial Intelligence in Human Papillomavirus Status Prediction for Oropharyngeal Cancer: A Scoping Review”
by Andrea Migliorelli, Marianna Manuelli, Andrea Ciorba, Francesco Stomeo, Stefano Pelucchi and Chiara Bianchini
Cancers 2024, 16(23), 4040; https://doi.org/10.3390/cancers16234040
Available online: https://www.mdpi.com/2072-6694/16/23/4040
13. “Evaluation of Automatic Signal Detection of In Situ Hybridization for Detecting HPV DNA in Cervical Tissue Derived from Patients with Cervical Intraepithelial Neoplasia”
by Marcin Przybylski, Sonja Millert-Kalińska, Mateusz de Mezer, Monika Krzyżaniak, Paweł Kurzawa, Jakub Żurawski, Robert Jach and Dominik Pruski
Cancers 2024, 16(20), 3485; https://doi.org/10.3390/cancers16203485
Available online: https://www.mdpi.com/2072-6694/16/20/3485
14 “Exploring the Link Between Obligate Anaerobe-Related Dysbiosis and Prostate Cancer Development: A Pilot Study”
by Efthymios Ladoukakis, Tim Oliver, Mark Wilks, Emily F. Lane, Frank Chinegwundoh, Greg Shaw and Belinda Nedjai
Cancers 2025, 17(1), 70; https://doi.org/10.3390/cancers17010070
Available online: https://www.mdpi.com/2072-6694/17/1/70
15. “Hepatitis B Virus-Induced Resistance to Sorafenib and Lenvatinib in Hepatocellular Carcinoma Cells: Implications for Cell Viability and Signaling Pathways”
by Narmen Esmael,Ido Lubin,Ran Tur-Kaspa and Romy Zemel
Cancers 2024, 16(22), 3763; https://doi.org/10.3390/cancers16223763
Available online: https://www.mdpi.com/2072-6694/16/22/3763
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
24 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Cancer Metastasis” Section

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Metastasis” Section, which are listed below:
1. “Comparative Efficacy of Adagrasib and Sotorasib in KRAS G12C-Mutant NSCLC: Insights from Pivotal Trials”
by Tzu-Rong Peng,Ta-Wei Wu,Tai-Yung Yi and An-Jan Wu
Cancers 2024, 16(21), 3676; https://doi.org/10.3390/cancers16213676
Available online: https://www.mdpi.com/2072-6694/16/21/3676
2. “FBXO11 Mediates Ubiquitination of ZEB1 and Modulates Epithelial to Mesenchymal Transition in Lung Cancer Cells”
by Xinyue Zhao, Zhihui Han, Ruiying Liu, Zehao Li, Ling Mei and Yue Jin
Cancers 2024, 16(19), 3269; https://doi.org/10.3390/cancers16193269
Available online: https://www.mdpi.com/2072-6694/16/19/3269
3. “Prevention of Brain Metastases: A New Frontier”
by Alessia Pellerino, Tara Marie Davidson, Shreyas S. Bellur, Manmeet S. Ahluwalia, Hussein Tawbi, Roberta Rudà and Riccardo Soffietti
Cancers 2024, 16(11), 2134; https://doi.org/10.3390/cancers16112134
Available online: https://www.mdpi.com/2072-6694/16/11/2134
4. “High M2-TAM Infiltration and STAT3/NF-?B Signaling Pathway as a Predictive Factor for Tumor Progression and Death in Cervical Cancer”
by George Alexandre Lira, Fábio Medeiros de Azevedo, Ingrid Gabrielle dos Santos Lins, Isabelle de Lima Marques, Giovanna Afonso Lira, Christina Eich and Raimundo Fernandes de Araujo Junior
Cancers 2024, 16(14), 2496; https://doi.org/10.3390/cancers16142496
Available online: https://www.mdpi.com/2072-6694/16/14/2496
5. “Genome-Wide CRISPR Screen Identifies Genes Involved in Metastasis of Pancreatic Ductal Adenocarcinoma”
by Risky Oktriani, Anna Chiara Pirona, Lili Kalmár, Ariani S. Rahadian, Beiping Miao, Andrea S. Bauer, Jörg D. Hoheisel, Michael Boettcher and Haoqi Du
Cancers 2024, 16(21), 3684; https://doi.org/10.3390/cancers16213684
Available online: https://www.mdpi.com/2072-6694/16/21/3684
6. “Exposed Phosphatidylserine as a Biomarker for Clear Identification of Breast Cancer Brain Metastases in Mouse Models”
by Lulu Wang, Alan H. Zhao, Chad A. Arledge, Fei Xing, Michael D. Chan, Rolf A. Brekken, Amyn A. Habib and Dawen Zhao
Cancers 2024, 16(17), 3088; https://doi.org/10.3390/cancers16173088
Available online: https://www.mdpi.com/2072-6694/16/17/3088
7. “Navigating Brain Metastases: Unveiling the Potential of 3-Tesla Intraoperative Magnetic Resonance Imaging”
by Ghaith Altawalbeh, Maria Goldberg, Michel Gustavo Mondragón-Soto, Chiara Negwer, Arthur Wagner, Jens Gempt, Bernhard Meyer and Amir Kaywan Aftahy
Cancers 2024, 16(16), 2774; https://doi.org/10.3390/cancers16162774
Available online: https://www.mdpi.com/2072-6694/16/16/2774
8. “Tracing Quiescent Cancer Cells In Vivo”
by Moon Jong Kim
Cancers 2024, 16(22), 3822; https://doi.org/10.3390/cancers16223822
Available online: https://www.mdpi.com/2072-6694/16/22/3822
9. “Predictive and Prognostic Factors in Melanoma Central Nervous System Metastases—A Cohort Study”
by Estefania Serra, Álvaro Abarzua-Araya, Ana Arance, Roberto Martin-Huertas, Francisco Aya, María Lourdes Olondo, Daniel Rizo-Potau, Josep Malvehy, Susana Puig, Cristina Carrera et al.
Cancers 2024, 16(12), 2272; https://doi.org/10.3390/cancers16122272
Available online: https://www.mdpi.com/2072-6694/16/12/2272
10. “TSH Stimulation before PET/CT as Our Frenemy in Detecting Thyroid Cancer Metastases—Final Results of a Retrospective Analysis”
by Maciej Kołodziej, Marek Saracyn, Arkadiusz Lubas, Dorota Brodowska-Kania, Andrzej Mazurek, Mirosław Dziuk, Adam Daniel Durma, Stanisław Niemczyk and Grzegorz Kamiński
Cancers 2024, 16(19), 3413; https://doi.org/10.3390/cancers16193413
Available online: https://www.mdpi.com/2072-6694/16/19/3413
11. “Inverse Correlation between pks-Carrying Escherichia coli Abundance in Colorectal Cancer Liver Metastases and the Number of Organs Involved in Recurrence”
by Yasuyuki Shigematsu, Rumiko Saito, Hiroaki Kanda, Yu Takahashi, Kengo Takeuchi, Shunji Takahashi and Kentaro Inamura
Cancers 2024, 16(17), 3003; https://doi.org/10.3390/cancers16173003
Available online: https://www.mdpi.com/2072-6694/16/17/3003
12. “Microbiome—Stealth Regulator of Breast Homeostasis and Cancer Metastasis”
by Saori Furuta
Cancers 2024, 16(17), 3040; https://doi.org/10.3390/cancers16173040
Available online: https://www.mdpi.com/2072-6694/16/17/3040
13. “Emerging Paradigms in Cancer Metastasis: Ghost Mitochondria, Vasculogenic Mimicry, and Polyploid Giant Cancer Cells”
by Mateusz Krotofil, Maciej Tota, Jakub Siednienko and Piotr Donizy
Cancers 2024, 16(20), 3539; https://doi.org/10.3390/cancers16203539
Available online: https://www.mdpi.com/2072-6694/16/20/3539
14.“The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer”
by David Han, Jonathan M. Spehar, Dillon S. Richardson, Sumudu Leelananda, Prathik Chakravarthy, Samantha Grecco, Jesse Reardon, Daniel G. Stover, Chad Bennett, Gina M. Sizemore et al.
Cancers 2024, 16(17), 3043; https://doi.org/10.3390/cancers16173043
Available online: https://www.mdpi.com/2072-6694/16/17/3043
15. “Role of Podoplanin (PDPN) in Advancing the Progression and Metastasis of Glioblastoma Multiforme (GBM)”
by Bharti Sharma,George Agriantonis,Zahra Shafaee, Kate Twelker, Navin D. Bhatia, Zachary Kuschner, Monique Arnold, Aubrey Agcon, Jasmine Dave, Juan Mestre et al.
Cancers 2024, 16(23), 4051; https://doi.org/10.3390/cancers16234051
Available online: https://www.mdpi.com/2072-6694/16/23/4051
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
21 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Cancer Epidemiology and Prevention” Section

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Epidemiology and Prevention” Section, which are listed below.
1. “Microplastics in the Human Body: Exposure, Detection, and Risk of Carcinogenesis: A State-of-the-Art Review”
by Eliasz Dzierżyński, Piotr J. Gawlik, Damian Puźniak, Wojciech Flieger, Katarzyna Jóźwik, Grzegorz Teresiński, Alicja Forma, Paulina Wdowiak, Jacek Baj and Jolanta Flieger
Cancers 2024, 16(21), 3703; https://doi.org/10.3390/cancers16213703
Available online: https://www.mdpi.com/2072-6694/16/21/3703
2. “Trends in Cancer Incidence and Mortality in US Adolescents and Young Adults, 2016–2021”
by Li Zhang, Joshua E. Muscat, Vernon M. Chinchilli and Chandrika G. Behura
Cancers 2024, 16(18), 3153; https://doi.org/10.3390/cancers16183153
Available online: https://www.mdpi.com/2072-6694/16/18/3153
3. “Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies”
by Siva Dallavalasa, SubbaRao V. Tulimilli, Vidya G. Bettada, Medha Karnik, Chinnappa A. Uthaiah, Preethi G. Anantharaju, Suma M. Nataraj, Rajalakshmi Ramashetty, Olga A. Sukocheva, Edmund Tse et al.
Cancers 2024, 16(18), 3211; https://doi.org/10.3390/cancers16183211
Available online: https://www.mdpi.com/2072-6694/16/18/3211
4. “Effects of Weight Loss on Key Obesity-Related Biomarkers Linked to the Risk of Endometrial Cancer: A Systematic Review and Meta-Analysis”
by Angela D. Clontz, Emma Gan, Stephen D. Hursting and Victoria L. Bae-Jump
Cancers 2024, 16(12), 2197; https://doi.org/10.3390/cancers16122197
Available online: https://www.mdpi.com/2072-6694/16/12/2197
5. “Real-World Survival Impact of New Treatment Strategies for Lung Cancer: A 2000–2020 French Cohort”
by Clemence Basse, Matthieu Carton, Maud Milder, Romain Geiss, Pauline Du Rusquec, Catherine Daniel, Marie-Ange Massiani, Alain Livartowski and Nicolas Girard
Cancers 2024, 16(15), 2768; https://doi.org/10.3390/cancers16152768
Available online: https://www.mdpi.com/2072-6694/16/15/2768
6. “Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment”
by Laia Lorenzo-Esteller, Raúl Ramos-Polo, Alexandra Pons Riverola, Herminio Morillas, Javier Berdejo, Sonia Pernas, Helena Pomares, Leyre Asiain, Alberto Garay, Evelyn Martínez Pérez et al.
Cancers 2024, 16(20), 3466; https://doi.org/10.3390/cancers16203466
Available online: https://www.mdpi.com/2072-6694/16/20/3466
7. “Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms”
by Anna Markowska, Michał Antoszczak, Janina Markowska and Adam Huczyński
Cancers 2024, 16(12), 2288; https://doi.org/10.3390/cancers16122288
Available online: https://www.mdpi.com/2072-6694/16/12/2288
8. “A Comprehensive Analysis of Skin Cancer Concerns and Protective Practices in Manitoba, Canada, Highlights Lack of Skin Cancer Awareness and Predominance of High-Risk Sun Exposure Behaviors”
by François Lagacé, Santina Conte, Lorena A. Mija, Amina Moustaqim-Barrette, Farhan Mahmood, Jonathan LeBeau, Alyson McKenna, Mahan Maazi, Johnny Hanna, Alexandra Sarah Victoria Kelly et al.
Cancers 2024, 16(17), 3093; https://doi.org/10.3390/cancers16173093
Available online: https://www.mdpi.com/2072-6694/16/17/3093
9. “The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer”
by Woong Ki Park, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Jai Min Ryu and Byung Joo Chae
Cancers 2024, 16(14), 2566; https://doi.org/10.3390/cancers16142566
Available online: https://www.mdpi.com/2072-6694/16/14/2566
10. “The Application of High-Frequency Ultrasonography in Post-Therapeutic Assessment of Actinic Keratosis After Photodynamic Therapy”
by Katarzyna Korecka, Anna Slian, Joanna Czajkowska, Aleksandra Dańczak-Pazdrowska and Adriana Polańska
Cancers 2024, 16(22), 3778; https://doi.org/10.3390/cancers16223778
Available online: https://www.mdpi.com/2072-6694/16/22/3778
11. “Lung Cancer and Interstitial Lung Diseases”
by Fotios Drakopanagiotakis, Ekaterina Krauss, Ira Michailidou, Vasileios Drosos, Stavros Anevlavis, Andreas Günther and Paschalis Steiropoulos
Cancers 2024, 16(16), 2837; https://doi.org/10.3390/cancers16162837
Available online: https://www.mdpi.com/2072-6694/16/16/2837
12. “Trends and Age–Period–Cohort Effect on the Incidence of Early-Onset Colorectal Cancer (20–44 Years) from 1990 to 2021 in the United States”
by Wafa A. Aldhaleei, Michael B. Wallace and Akshaya Srikanth Bhagavathula
Cancers 2024, 16(16), 2883; https://doi.org/10.3390/cancers16162883
Available online: https://www.mdpi.com/2072-6694/16/16/2883
13. “The Association between Medroxyprogesterone Acetate Exposure and Meningioma”
by Russell L. Griffin
Cancers 2024, 16(19), 3362; https://doi.org/10.3390/cancers16193362
Available online: https://www.mdpi.com/2072-6694/16/19/3362
14. “Imaging Biomarkers of Oral Dysplasia and Carcinoma Measured with In Vivo Endoscopic Optical Coherence Tomography”
by Jeanie Malone, Chloe Hill, Adrian Tanskanen, Kelly Liu, Samson Ng, Calum MacAulay, Catherine F. Poh and Pierre M. Lane
Cancers 2024, 16(15), 2751; https://doi.org/10.3390/cancers16152751
Available online: https://www.mdpi.com/2072-6694/16/15/2751
15. “SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells”
by Marco Colella, Andrea Iannucci, Claudia Maresca, Francesco Albano, Carmela Mazzoccoli, Federica Laudisi, Ivan Monteleone and Giovanni Monteleone
Cancers 2024, 16(13), 2370; https://doi.org/10.3390/cancers16132370
Available online: https://www.mdpi.com/2072-6694/16/13/2370
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
20 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the Section “Cancer Therapy”

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Therapy” Section, which are listed below.
1. “Transarterial Chemoembolization Treatment Paradigms for Hepatocellular Carcinoma”
by Elliott L. Fite and Mina S. Makary
Cancers 2024, 16(13), 2430; https://doi.org/10.3390/cancers16132430
Available online: https://www.mdpi.com/2072-6694/16/13/2430
2. “De-Escalation of Axillary Surgery in Clinically Node-Positive Breast Cancer Patients Treated with Neoadjuvant Therapy: Comparative Long-Term Outcomes of Sentinel Lymph Node Biopsy versus Axillary Lymph Node Dissection”
by Corrado Tinterri, Erika Barbieri, Andrea Sagona, Simone Di Maria Grimaldi and Damiano Gentile
Cancers 2024, 16(18), 3168; https://doi.org/10.3390/cancers16183168
Available online: https://www.mdpi.com/2072-6694/16/18/3168
3. “The Treatment of Hepatocellular Carcinoma with Major Vascular Invasion”
by Tomoko Tadokoro, Joji Tani, Asahiro Morishita, Koji Fujita, Tsutomu Masaki and Hideki Kobara
Cancers 2024, 16(14), 2534; https://doi.org/10.3390/cancers16142534
Available online: https://www.mdpi.com/2072-6694/16/14/2534
4. “Review of Current and Future Medical Treatments in Head and Neck Squamous Cell Carcinoma”
by Aaron M. Lee, Alice N. Weaver, Phillip Acosta, Lauren Harris and Daniel W. Bowles
Cancers 2024, 16(20), 3488; https://doi.org/10.3390/cancers16203488
Available online: https://www.mdpi.com/2072-6694/16/20/3488
5. “The Role of MRI in Breast Cancer and Breast Conservation Therapy”
by Iman Washington, Russell F. Palm, Julia White, Stephen A. Rosenberg and Dana Ataya
Cancers 2024, 16(11), 2122; https://doi.org/10.3390/cancers16112122
Available online: https://www.mdpi.com/2072-6694/16/11/2122
6. “Exploring Extravasation in Cancer Patients”
by Tuan D. Pham and Taichiro Tsunoyama
Cancers 2024, 16(13), 2308; https://doi.org/10.3390/cancers16132308
Available online: https://www.mdpi.com/2072-6694/16/13/2308
7. “Epidemiology of Gastric Cancer—Changing Trends and Global Disparities”
by Manami Inoue
Cancers 2024, 16(17), 2948; https://doi.org/10.3390/cancers16172948
Available online: https://www.mdpi.com/2072-6694/16/17/2948
8. “Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer”
by Prabhjot Kaur, Santosh Kumar Singh, Manoj K. Mishra, Shailesh Singh and Rajesh Singh
Cancers 2024, 16(12), 2205; https://doi.org/10.3390/cancers16122205
Available online: https://www.mdpi.com/2072-6694/16/12/2205
9. “Epigenetic Therapies in Triple-Negative Breast Cancer: Concepts, Visions, and Challenges”
by Ulrich Lehmann
Cancers 2024, 16(12), 2164; https://doi.org/10.3390/cancers16122164
Available online: https://www.mdpi.com/2072-6694/16/12/2164
10. “Theranostic Approaches for Gastric Cancer: An Overview of In Vitro and In Vivo Investigations”
by Ghazal Basirinia, Muhammad Ali, Albert Comelli, Alessandro Sperandeo, Sebastiano Piana, Pierpaolo Alongi, Costanza Longo, Domenico Di Raimondo, Antonino Tuttolomondo and Viviana Benfante
Cancers 2024, 16(19), 3323; https://doi.org/10.3390/cancers16193323
Available online: https://www.mdpi.com/2072-6694/16/19/3323
11. “Current Applications and Future Directions of Circulating Tumor Cells in Colorectal Cancer Recurrence”
by Kun-Yu Tsai, Po-Shuan Huang, Po-Yu Chu, Thi Ngoc Anh Nguyen, Hsin-Yuan Hung, Chia-Hsun Hsieh and Min-Hsien Wu
Cancers 2024, 16(13), 2316; https://doi.org/10.3390/cancers16132316
Available online: https://www.mdpi.com/2072-6694/16/13/2316
12. “Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma”
by Md Ataur Rahman and Meser M. Ali
Cancers 2024, 16(17), 2975; https://doi.org/10.3390/cancers16172975
Available online: https://www.mdpi.com/2072-6694/16/17/2975
13. “Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy”
by Neda Dadgar, Arun K. Arunachalam, Hanna Hong, Yee Peng Phoon, Jorge E. Arpi-Palacios, Melis Uysal, Chase J. Wehrle, Federico Aucejo, Wen Wee Ma and Jan Joseph Melenhorst
Cancers 2024, 16(18), 3232; https://doi.org/10.3390/cancers16183232
Available online: https://www.mdpi.com/2072-6694/16/18/3232
14. “Rare Clinical Symptoms in Hairy Cell Leukemia: An Overview”
by Tadeusz Robak, Marcin Braun, Agnieszka Janus, Anna Guminska and Ewa Robak
Cancers 2024, 16(17), 3054; https://doi.org/10.3390/cancers16173054
Available online: https://www.mdpi.com/2072-6694/16/17/3054
15. “Advancements in First-Line Treatment of Metastatic Bladder Cancer: EV-302 and Checkmate-901 Insights and Future Directions”
by Vijay Kumar Srinivasalu and Debbie Robbrecht
Cancers 2024, 16(13), 2398; https://doi.org/10.3390/cancers16132398
Available online: https://www.mdpi.com/2072-6694/16/13/2398
You are invited to view and submit relevant papers to the journal Cancers.
Cancers Editorial Office
18 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the Section “Cancer Biomarkers”

Cancers (ISSN: 2072-6694) is an open access journal, allowing you to have free and unlimited access to all full-text articles. We welcome you to read the following feature papers published in the second half of 2024 in the “Cancer Biomarkers” Section:
1. “Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis”
by Taha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo and Deniz Can Guven
Cancers 2024, 16(21), 3689; https://doi.org/10.3390/cancers16213689
Available online: https://www.mdpi.com/2072-6694/16/21/3689
2. “Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review”
by Juan Carlos Restrepo, Darly Martínez Guevara, Andrés Pareja López, John Fernando Montenegro Palacios and Yamil Liscano
Cancers 2024, 16(13), 2338; https://doi.org/10.3390/cancers16132338
Available online: https://www.mdpi.com/2072-6694/16/13/2338
3. “Advances in Personalized Oncology”
by Hiba Mechahougui, James Gutmans, Gina Colarusso, Roumaïssa Gouasmi and Alex Friedlaender
Cancers 2024, 16(16), 2862; https://doi.org/10.3390/cancers16162862
Available online: https://www.mdpi.com/2072-6694/16/16/2862
4. “Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers”
by Prerna Dabral, Nobel Bhasin,Manish Ranjan, Maysoon M. Makhlouf and Zakaria Y. Abd Elmageed
Cancers 2024, 16(13), 2462; https://doi.org/10.3390/cancers16132462
Available online: https://www.mdpi.com/2072-6694/16/13/2462
5. “Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review”
by Karam Ashouri, Alexandra Wong, Pooja Mittal, Lesly Torres-Gonzalez, Jae Ho Lo, Shivani Soni, Sandra Algaze, Taline Khoukaz, Wu Zhang, Yan Yang, Joshua Millstein et al.
Cancers 2024, 16(16), 2796; https://doi.org/10.3390/cancers16162796
Available online: https://www.mdpi.com/2072-6694/16/16/2796
6. “Telomere Length and Telomerase Activity as Potential Biomarkers for Gastrointestinal Cancer”
by Christina Loukopoulou, Taxiarchis Nikolouzakis, Ioannis Koliarakis, Elena Vakonaki and John Tsiaoussis
Cancers 2024, 16(19), 3370; https://doi.org/10.3390/cancers16193370
Available online: https://www.mdpi.com/2072-6694/16/19/3370
7. “Defensins: Exploring Their Opposing Roles in Colorectal Cancer Progression”
by Hussein Sabit, Timothy M. Pawlik, Shaimaa Abdel-Ghany and Borros Arneth
Cancers 2024, 16(15), 2622; https://doi.org/10.3390/cancers16152622
Available online: https://www.mdpi.com/2072-6694/16/15/2622
8. “Enhancing Immunotherapy Response Prediction in Metastatic Lung Adenocarcinoma: Leveraging Shallow and Deep Learning with CT-Based Radiomics across Single and Multiple Tumor Sites”
by Cécile Masson-Grehaigne, Mathilde Lafon, Jean Palussière, Laura Leroy, Benjamin Bonhomme, Eva Jambon, Antoine Italiano, Sophie Cousin and Amandine Crombé
Cancers 2024, 16(13), 2491; https://doi.org/10.3390/cancers16132491
Available online: https://www.mdpi.com/2072-6694/16/13/2491
9. “Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma”
by Cassandra Cieslak, Carsten Hain, Christian Rückert-Reed, Tobias Busche, Levin Joe Klages, Katrin Schaper-Gerhardt, Ralf Gutzmer, Jörn Kalinowski and Rudolf Stadler
Cancers 2024, 16(21), 3700; https://doi.org/10.3390/cancers16213700
Available online: https://www.mdpi.com/2072-6694/16/21/3700
10. “Fantastic Frogs and Where to Use Them: Unveiling the Hidden Cinobufagin’s Promise in Combating Lung Cancer Development and Progression Through a Systematic Review of Preclinical Evidence”
by Sandra Maria Barbalho, Karina Torres Pomini, Enzo Pereira de Lima, Jéssica da Silva Camarinha Oliveira, Beatriz Leme Boaro, Adriano Cressoni Araújo, Elen Landgraf Guiguer, Rose Eli Grassi Rici, Durvanei Augusto Maria, Jesselina Francisco dos Santos Haber et al.
Cancers 2024, 16(22), 3758; https://doi.org/10.3390/cancers16223758
Available online: https://www.mdpi.com/2072-6694/16/22/3758
11. “Exploring miRNA Profiles in Colon Cancer: A Focus on miR101-3p, miR106a-5p, and miR326”
by Constantin-Dan Tâlvan, Elena-Teodora Tâlvan, Călin Ilie Mohor, Liviuța Budișan, Valentin Grecu, Manuela Mihalache, Oana Zănoagă, Sergiu Chira, Ioana Berindan-Neagoe, Victor Cristea et al.
Cancers 2024, 16(12), 2285; https://doi.org/10.3390/cancers16122285
Available online: https://www.mdpi.com/2072-6694/16/12/2285
12. “Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?”
by Felix Peisen, Annika Gerken, Alessa Hering, Isabel Dahm, Konstantin Nikolaou, Sergios Gatidis, Thomas K. Eigentler, Teresa Amaral, Jan H. Moltz and Ahmed E. Othman
Cancers 2024, 16(15), 2669; https://doi.org/10.3390/cancers16152669
Available online: https://www.mdpi.com/2072-6694/16/15/2669
13. “Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer?”
by Alvan Cai, Yuan Chen, Lily S. Wang, John K. Cusick and Yihui Shi
Cancers 2024, 16(15), 2635; https://doi.org/10.3390/cancers16152635
Available online: https://www.mdpi.com/2072-6694/16/15/2635
14. “Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic Implications?”
by Margo B. Gerke, Caroline S. Jansen and Mehmet A. Bilen
Cancers 2024, 16(12), 2280; https://doi.org/10.3390/cancers16122280
Available online: https://www.mdpi.com/2072-6694/16/12/2280
15. “Artificial Intelligence in Head and Neck Cancer Diagnosis: A Comprehensive Review with Emphasis on Radiomics, Histopathological, and Molecular Applications?”
by Giuseppe Broggi, Antonino Maniaci, Mario Lentini, Andrea Palicelli, Magda Zanelli, Maurizio Zizzo, Nektarios Koufopoulos, Serena Salzano, Manuel Mazzucchelli and Rosario Caltabiano
Cancers 2024, 16(21), 3623; https://doi.org/10.3390/cancers16213623
Available online: https://www.mdpi.com/2072-6694/16/21/3623
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
18 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the Section “Systematic Review or Meta–Analysis in Cancer Research”

Cancers (ISSN: 2072-6694) is an open access journal, allowing you to have free and unlimited access to all full-text articles. We welcome you to read the following feature papers published in the second half of 2024 in the “Systematic Review or Meta-Analysis in Cancer Research” Section:
1. “A Systematic Review of Cost-Effectiveness Studies on Gastric Cancer Screening”
by Diedron Lewis, Laura Jimenez, Manel Haj Mansour, Susan Horton and William W. L. Wong
Cancers 2024, 16(13), 2353; https://doi.org/10.3390/cancers16132353
Available online: https://www.mdpi.com/2072-6694/16/13/2353
2. “Exposure to Light at Night and Risk of Cancer: A Systematic Review, Meta-Analysis, and Data Synthesis”
by Samuel Ma, Yossef Alsabawi, Hashem B El-Serag and Aaron P Thrift
Cancers 2024, 16(15), 2653; https://doi.org/10.3390/cancers16152653
Available online: https://www.mdpi.com/2072-6694/16/15/2653
3. “Repeat Faecal Immunochemical Testing for Colorectal Cancer Detection in Symptomatic and Screening Patients: A Systematic Review and Meta-Analysis”
by Adam D. Gerrard, Roberta Garau, Wei Xu, Yasuko Maeda, Malcolm G. Dunlop, Evropi Theodoratou and Farhat V. N. Din
Cancers 2024, 16(18), 3199; https://doi.org/10.3390/cancers16183199
Available online: https://www.mdpi.com/2072-6694/16/18/3199
4. “The Prognostic Role of Perineural Invasion for Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis”
by Zhuo-Ying Tao, Guang Chu and Yu-Xiong Su
Cancers 2024, 16(14), 2514; https://doi.org/10.3390/cancers16142514
Available online: https://www.mdpi.com/2072-6694/16/14/2514
5. “Efficacy and Safety of Fluorescence-Guided Surgery Compared to Conventional Surgery in the Management of Colorectal Cancer: A Systematic Review and Meta-Analysis”
by Michael G. Fadel, Elham Zonoobi, María Rita Rodríguez-Luna, Kohei Mishima, Frédéric Ris, Michele Diana, Alexander L. Vahrmeijer, Silvana Perretta, Hutan Ashrafian and Matyas Fehervari
Cancers 2024, 16(19), 3377; https://doi.org/10.3390/cancers16193377
Available online: https://www.mdpi.com/2072-6694/16/19/3377
6. “Biphenotypic Sinonasal Sarcoma with Orbital Invasion: A Literature Review and Modular System of Surgical Approaches”
by Sergio Corvino, Oreste de Divitiis, Adriana Iuliano, Federico Russo, Giuseppe Corazzelli, Dana Cohen, Rosa Maria Di Crescenzo, Carmela Palmiero, Giuseppe Pontillo, Stefania Staibano et al.
Cancers 2024, 16(19), 3316; https://doi.org/10.3390/cancers16193316
Available online: https://www.mdpi.com/2072-6694/16/19/3316
7. “Systematic Review and Meta-Analysis of Particle Beam Therapy versus Photon Radiotherapy for Skull Base Chordoma: TRP-Chordoma 2024”
by Takashi Saito, Masashi Mizumoto, Yoshiko Oshiro, Shosei Shimizu, Yinuo Li, Masatoshi Nakamura, Sho Hosaka, Kei Nakai, Takashi Iizumi, Masako Inaba et al.
Cancers 2024, 16(14), 2569; https://doi.org/10.3390/cancers16142569
Available online: https://www.mdpi.com/2072-6694/16/14/2569
8. “Sentinel Lymph Node Detection in Cutaneous Melanoma Using Indocyanine Green-Based Near-Infrared Fluorescence Imaging: A Systematic Review and Meta-Analysis”
by Marcus Wölffer, Rémy Liechti, Mihai Constantinescu, Ioana Lese and Cédric Zubler
Cancers 2024, 16(14), 2523; https://doi.org/10.3390/cancers16142523
Available online: https://www.mdpi.com/2072-6694/16/14/2523
9. “Ultra-Processed Food and Prostate Cancer Risk: A Systemic Review and Meta-Analysis”
by Cayla Fichtel-Epstein, Janice Huang, Benjamin James Rich, Crystal Seldon Taswell, Derek Isrow and William Jin
Cancers 2024, 16(23), 3953; https://doi.org/10.3390/cancers16233953
Available online: https://www.mdpi.com/2072-6694/16/23/3953
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office